Jan 8 (Reuters) – On Thursday, Johnson & Johnson announced that it has struck a deal with the administration of U.S. President Donald Trump to lower drug prices for American consumers in return for exemptions from U.S. tariffs. (Reporting by Rhea Rose Abraham in Bengaluru; Editing by Sherry Jacob-Phillips)